Preanalytical standardization of sphingosine-1-phosphate, sphinganine-1-phosphate and sphingosine analysis in human plasma by liquid chromatography-tandem mass spectrometry

Clinica Chimica Acta

Volumn 435, Issue , 2014, Pages 1-6

  Ceglarek, Uta ^a,b   Dittrich, Julia ^a,b   Helmschrodt, Christin ^a,b   Wagner, Kristin ^a,b   Nofer, Jerzy Roch ^c   Thiery, Joachim ^a,b   Becker, Susen ^a,b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

HILIC; Human plasma; Preanalytical standardization; Sphingolipids; Tandem mass spectrometry

Indexed keywords

SPHINGANINE; SPHINGANINE 1 PHOSPHATE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ANIMAL CELL; ARTICLE; BLOOD SAMPLING; FEMALE; FREEZE THAWING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RELIABILITY; ROOM TEMPERATURE; STANDARDIZATION; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; VALIDITY;

EID: 84899828124     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.04.010     Document Type: Article

References (24)

1. Lan T., Bi H., Liu W., Xie X., Xu S., Huang H. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2011, 879:520-526.
2. Scherer M., Leuthauser-Jaschinski K., Ecker J., Schmitz G., Liebisch G. A rapid and quantitative LC-MS/MS method to profile sphingolipids. J Lipid Res 2010, 51:2001-2011.
3. Schmidt H., Schmidt R., Geisslinger G. LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. Prostaglandins Other Lipid Mediat 2006, 81:162-170.
4. Bartke N., Hannun Y.A. Bioactive sphingolipids: metabolism and function. J Lipid Res 2009, 50:S91-S96.
5. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003, 4:397-407.
6. Scherer M., Schmitz G., Liebisch G. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. Clin Chem 2009, 55:1218-1222.
7. Yatomi Y., Igarashi Y., Yang L., et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 1997, 121:969-973.
8. Holland W.L., Summers S.A. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 2008, 29:381-402.
9. Summers S.A., Nelson D.H. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 2005, 54:591-602.
10. Hla T. Physiological and pathological actions of sphingosine-1-phosphate. Semin Cell Dev Biol 2004, 15:513-520.
11. Rosen H., Goetzl E.J. Sphingosine-1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 2005, 5:560-570.
12. Wymann M.P., Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008, 9:162-176.
13. Merrill A.H., Stokes T.H., Momin A., et al. Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J Lipid Res 2009, 50:S97-S102. [Supplement].
14. Cutignano A., Chiuminatto U., Petruzziello F., Vella F.M., Fontana A. UPLC-MS/MS method for analysis of sphingosine 1-phosphate in biological samples. Prostaglandins Other Lipid Mediat 2010, 93:25-29.
15. Liebisch G., Scherer M. Quantification of bioactive sphingo- and glycerophospholipid species by electrospray ionization tandem mass spectrometry in blood. J Chromatogr B Analyt Technol Biomed Life Sci 2012, 883-884:141-146.
16. Scherer M., Bottcher A., Schmitz G., Liebisch G. Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry. Biochim Biophys Acta 1811, 2011:68-75.
17. Allende M.L., Sasaki T., Kawai H., et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 2004, 279:52487-52492.
18. Mizugishi K., Yamashita T., Olivera A., Miller G.F., Spiegel S., Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005, 25:11113-11121.
19. ISO 5725-6 I Accuracy (trueness and precision) of measurement methods and results. Part 6: use in practice of accuracy values 1994.
20. Andréani P., Gräler M.H. Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction. Anal Biochem 2006, 358:239-246.
21. Yatomi Y., Ruan F., Hakomori S., Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995, 86:193-202.
22. Tani M., Sano T., Ito M., Igarashi Y. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. J Lipid Res 2005, 46:2458-2467.
23. Yin P., Peter A., Franken H., et al. Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem 2013, 59:833-845.
24. Murph M., Tanaka T., Pang J., et al. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. Methods Enzymol 2007, 433:1-25.